2.42
+0.035(+1.47%)
Currency In USD
| Previous Close | 2.38 |
| Open | 2.38 |
| Day High | 2.55 |
| Day Low | 2.37 |
| 52-Week High | 4.67 |
| 52-Week Low | 0.93 |
| Volume | 2.73M |
| Average Volume | 3.3M |
| Market Cap | 110.05M |
| PE | -5.37 |
| EPS | -0.45 |
| Moving Average 50 Days | 2.41 |
| Moving Average 200 Days | 2.53 |
| Change | 0.04 |
If you invested $1000 in Microbot Medical Inc. (MBOT) 10 years ago, it would be worth $3.24 as of December 14, 2025 at a share price of $2.415. Whereas If you bought $1000 worth of Microbot Medical Inc. (MBOT) shares 5 years ago, it would be worth $337.29 as of December 14, 2025 at a share price of $2.415.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
GlobeNewswire Inc.
Nov 26, 2025 1:30 PM GMT
Adoption of LIBERTY is Consistent with Emory’s Commitment to the Growing and Evolving Field of Interventional RadiologyHINGHAM, Mass., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovati
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
GlobeNewswire Inc.
Nov 05, 2025 1:30 PM GMT
Harel Gadot, President and CEO, Microbot Medical Announces LIBERTY® Limited Market Release Company Completes the Required Infrastructure to Support the Introduction of LIBERTY® to the U.S. Market with the Hiring of the Core Commercial Team and
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
GlobeNewswire Inc.
Oct 16, 2025 12:30 PM GMT
First U.S. Based Medical Meeting Presence Post-FDA Clearance Will Allow the Company to Commercially Engage Future Potential Users of the LIBERTY® System Company Completes the Recruitment of its Commercial Leadership Team as it Remains On Track to Co